A gene that cleans up the old material in cells can hold key to slow down human aging after researchers found that it boosted the life spans of fruit flies.
When researchers manipulated the neurons of fruit flies to contain higher levels of the gene, known as parkin, they lived 28 percent longer and remained healthy, said the study in the Proceedings of the National Academy of Sciences.
Genetic Testing of Diseases
Genetic testing helps to confirm a genetic condition in an individual and involves q complex laboratory techniques
Advertisement
"Just by increasing the levels of parkin, they live substantially longer while remaining healthy, active and fertile," said lead author Anil Rana, a postdoctoral scholar at the University of California, Los Angeles.
"That is what we want to achieve in aging research -- not only to increase their life span but to increase their health span as well."
Parkin has been previously implicated in the development of Parkinson's disease.
![Epigenetics]( "Epigenetics")
In the recent years 'epigenetics' represents inheritable changes in gene expression that do not include DNA alterations.
People born with a mutation in the parkin gene are at higher risk for developing early onset symptoms of Parkinson's, which typically develops in older adults.
Further study may reveal whether humans could experience a similar longevity boost from higher levels of parkin, which marks damaged proteins so that cells can discard them before they become toxic.
Parkin is also thought to be instrumental in removing damaged mitochondria from the cells.
"Our research may be telling us that parkin could be an important therapeutic target for neurodegenerative diseases and perhaps other diseases of aging," said senior author David Walker, an associate professor of integrative biology and physiology at UCLA.
"Instead of studying the diseases of aging one by one -- Parkinson's disease, Alzheimer's disease, cancer, stroke, cardiovascular disease, diabetes -- we believe it may be possible to intervene in the aging process and delay the onset of many of these diseases," he added.
"We are not there yet, and it can, of course, take many years, but that is our goal."
Source: AFP
Parkin has been previously implicated in the development of Parkinson's disease.
Epigenetics
In the recent years 'epigenetics' represents inheritable changes in gene expression that do not include DNA alterations.
Advertisement
People born with a mutation in the parkin gene are at higher risk for developing early onset symptoms of Parkinson's, which typically develops in older adults.
Further study may reveal whether humans could experience a similar longevity boost from higher levels of parkin, which marks damaged proteins so that cells can discard them before they become toxic.
Parkin is also thought to be instrumental in removing damaged mitochondria from the cells.
"Our research may be telling us that parkin could be an important therapeutic target for neurodegenerative diseases and perhaps other diseases of aging," said senior author David Walker, an associate professor of integrative biology and physiology at UCLA.
"Instead of studying the diseases of aging one by one -- Parkinson's disease, Alzheimer's disease, cancer, stroke, cardiovascular disease, diabetes -- we believe it may be possible to intervene in the aging process and delay the onset of many of these diseases," he added.
"We are not there yet, and it can, of course, take many years, but that is our goal."
Source: AFP
Birth Defect - Genetic
Achondroplasia is a genetic disorder which is one of the leading causes of dwarfism
Advertisement
Advertisement
|
Advertisement
Recommended Reading
Latest Genetics & Stem Cells News
Scientists have developed the first humanized mouse model for a rare hereditary condition.
A recent study discovered that the placenta, rather than only the brain, is crucial in determining the genetic risk of schizophrenia.
FOXI3 gene was found to be involved in Goldenhar syndrome, one form of developmental disorder, revealed research.
Contrary to previous beliefs, genes may not be fixed and can be influenced by environmental factors and lifestyle choices, according to modern scientific research.
Gene therapy successfully tested on dogs with inherited eye disease is now poised for clinical use in humans.